Building on these insights, this study aims to evaluate the role of manidipine in reversing P-gp-mediated MDR by exploring its effects on calcium signaling via NFAT2 activity to elucidate the molecular mechanisms underlying its potential to enhance chemotherapeutic efficacy and provide a foundation for future clinical applications in MDR cancer therapy. This evidence concerns the gene NFATC1 and cancer.